The Patent Finder

Decipher Biosciences, Inc.

0 patents currently held · Updated Nov 21, 2026
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Veracyte, Inc. (2023)

0
Ending by 2030
none
Next term end

When these terms end

Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

No patent on this record is in force and held under this name now.

Also on record: 14 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 3 abandoned

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/261,638Use of Immune Content Scores Diagnostically to Predict Responsiveness of Prostate Cancer Patients to ImmunotherapyJan 13, 2022Pending
17/561,408Molecular Subtyping, Prognosis, and Treatment of Bladder CancerDec 23, 2021Pending
18/037,885Methods and Genomic Classifiers for Identifying Homologous Recombination Deficiency Prostate CancerNov 18, 2021Pending
17/390,674Genetic Signatures to Predict Prostate Cancer Metastasis and Identify Tumor AggressivenessJul 30, 2021Abandoned
17/346,106Cancer Diagnostics Using BiomarkersJun 11, 2021Abandoned
17/915,646Genomic Classifiers for Prognosing and Treating Clinically Aggressive Luminal Bladder CancerMar 31, 2021Pending
17/611,545Non-Coding Rna for Subtyping of Bladder CancerMay 12, 2020Pending
17/311,995Transcriptomic Profiling for Prognosis of Breast Cancer to Identify Subjects Who May Be Spared Adjuvant Systemic TherapyDec 6, 2019Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited